MetaCap

Kewaunee Scientific Corporation (KEQU)

NASDAQ: KEQUIndustrialsMedical SpecialitiesUSD

33.55-0.95 (-2.75%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

KEQU stock chart

Technical analysis

Key statistics

All statistics
Market cap
$97.14M
Ex-dividend date
Sep 9, 2019
52-week range
32.00 – 43.36
Day range
33.55 – 33.98
Volume / Avg
524 / 4.21K
Beta
—
Next earnings
Dec 9, 2026

52-week range

$32.00$43.36

KEQU stock today

On Nov 20, KEQU ended the session at $33.55, shedding $0.95 (2.75%), versus the S&P 500's 3.70% decline. Trading was light, with 524 shares changing hands, about 12% of the average daily volume. At this level, KEQU sits near the bottom of its 52-week range of $32.00 to $43.36: 22.6% below the high, set on Mar 10, 2026 and 4.8% above the low.

KEQU is down 10.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 14.4%. Kewaunee Scientific trades at 12.2x its trailing twelve-month earnings per share of $2.76. Its forward P/E of 15.5x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. The company is scheduled to report Oct/2026 results on Dec 9.

Summary generated from market data by MetaCap's automated system. Methodology

About Kewaunee Scientific

Company profile

Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segments, Lab Products Group (LPG) and International. The company offers steel and wood casework and laboratory cabinetry, fume hoods, adaptable modular and flexible systems, movable workstations, stand-alone and work benches, computer enclosures, biological safety cabinets, CO2 incubators, ultralow freezers, epoxy resin work surfaces and sinks, and other laboratory products.

Industry
Medical Specialities
CEO
Mr. Thomas David Hull III
Headquarters
Statesville, NC
Employees
1,231

Financial highlights

Full financials

In fiscal 2026, Kewaunee Scientific generated $282.0 million in revenue, up 17.3% from fiscal 2025, its 2nd consecutive year of revenue growth. Net income was $9.6 million (-15.7% year over year), for a net margin of 3.4% versus a median of 0.3% in the prior 5 years. Gross margin was 28.5% (down from 28.6%) and operating margin 5.9%.

Kewaunee Scientific annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$282.00M$240.47M$203.75M$219.49M$168.87M
Growth+17.27%+18.02%-7.17%+29.98%+14.51%
Net income$9.62M$11.40M$18.75M$738.00K$-6.13M
EPS (diluted)$3.22$3.83$6.38$0.25$-2.20

Earnings

Earnings history
Next report
Dec 9, 2026
Last reported (Q1 2027)
Sep 9, 2026
EPS actual vs est.
$0.58 vs —

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$0.19
Ex-dividend date
Sep 9, 2019

KEQU news

All KEQU news

Kewaunee Scientific peers

Industrials sector
KEQU peer companies
CompanyPrice% ChgMarket capCompare
XGNExagen Inc.3.61-5.00%$92.10Mvs KEQU
BDSXBiodesix Inc.7.56-8.92%$83.83Mvs KEQU
SERASera Prognostics Inc. Class A1.81-4.23%$71.98Mvs KEQU
BNRBurning Rock Biotech Limited ADR13.24-0.60%$139.63Mvs KEQU
TLSITriSalus Life Sciences Inc.2.32+6.67%$143.14Mvs KEQU
MDXHMDxHealth SA0.1074-8.52%$10.25Mvs KEQU
AMSAmerican Shared Hospital Services1.00-4.76%$6.67Mvs KEQU
ACONAclarion Inc.1.22-13.92%$3.52Mvs KEQU

Indexes, lists and sector

Kewaunee Scientific stock FAQ

What is Kewaunee Scientific's stock price today?

KEQU last traded at $33.55 as of Nov 20, 4:00 PM EST, down 2.75% on the day. Prices are delayed at least 15 minutes.

Does Kewaunee Scientific pay a dividend?

Yes. Kewaunee Scientific pays $0.00 per share annually. The most recent dividend of $0.19 had an ex-dividend date of Sep 9, 2019.

When is Kewaunee Scientific's next earnings date?

Kewaunee Scientific is expected to report earnings on Wednesday, December 9, 2026.

What is KEQU's P/E ratio?

KEQU trades at a trailing P/E ratio of 12.16 and a forward P/E of 15.53.

Who is Kewaunee Scientific's CEO?

Mr. Thomas David Hull III is the chief executive officer of Kewaunee Scientific Corporation, which has about 1,231 employees.

Has KEQU ever split its stock?

Yes. The most recent KEQU stock split was a 3-for-2 split on Jan 7, 1985, one of 2 splits on record.

What is the KEQU 52-week high?

The 52-week high for KEQU is $43.36 and the 52-week low is $32.00. The stock is currently 22.6% below its high.

Compare KEQU